Get started
Author

Sakshi V. Khairnar

Observed names: S.V. Khairnar, Sakshi Khairnar, Sakshi V Khairnar
ORCID: 0009-0007-2187-8305
Observed ORCID: 0009-0007-2187-8305
OpenAlex ID: A5064098722
Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles
2022 · Sakshi V. Khairnar, Pritha Pagare, et al. · Pharmaceutics · 291
PDF
Redefining the importance of polylactide-co-glycolide acid (PLGA) in drug delivery
2021 · Y.R. Chavan, S.M. Tambe, et al. · Annales Pharmaceutiques Françaises · 69
Strategies to overcome antibiotic resistance: silver nanoparticles and vancomycin in pathogen eradication
2025 · Sakshi V. Khairnar, Ashish Das, et al. · RSC Pharmaceutics · 48
PDF
Nebulizer Systems: A New Frontier for Therapeutics and Targeted Delivery
2021 · Sakshi V Khairnar, Divya D Jain, et al. · Therapeutic Delivery · 36
In silico ADME/Pharmacokinetic and Target Prediction Studies of Ethambutol as Drug Molecule
2022 · Arnav Ajinkya Joshi, Sakshi V. Khairnar, et al. · Infectious Disorders - Drug Targets · 7
Chitosan-coated silver nanoparticles amplify glycopeptide efficacy against Staphylococcus aureus
2026 · Sakshi V. Khairnar, Anna Sommers, et al. · Frontiers in Microbiology · 1
PDF
Author response for "Strategies to Overcome Antibiotic Resistance: Silver Nanoparticles and Vancomycin in Pathogen Eradication"
2025 · Sakshi Khairnar, Ashish Das, et al. · Publons reviews and discussion
Works count: 7
Citation count: 452
H-index: 5
I10-index: 4
Year
Topic
Type